id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1988-N-0028-0002,FDA,FDA-1988-N-0028,FDA,Notice,NAD-Notice of Availability of Data,1994-12-27T05:00:00Z,1994,12,1994-12-27T05:00:00Z,1995-03-15T04:59:59Z,2008-05-30T22:53:14Z,,0,0,0900006480476632
FDA-1991-N-0041-0004,FDA,FDA-1991-N-0041,Medical Devices; Substantial Equivalence; 510(k) Summaries and 510(k) Statements; Class III Summaries; Confidentiality of Information,Notice,Notice of Final Rule,1994-12-20T05:00:00Z,1994,12,,,2023-09-01T14:49:14Z,94-30422,0,0,090000648052a20f
FDA-1994-F-0010-0001,FDA,FDA-1994-F-0010,"Roquette America, Inc.; Filing of Food Additive Petition",Notice,Notice of Filing,1994-12-15T05:00:00Z,1994,12,1994-12-15T05:00:00Z,1995-01-13T04:59:59Z,2024-05-28T14:03:33Z,94-30585,0,0,09000064804fc65b
FDA-1981-N-0043-0004,FDA,FDA-1981-N-0043,Marketing of Over-the-Counter Pediculicide Drug Products; Background Documents; Availability,Notice,Notice of Data Availability,1994-12-13T05:00:00Z,1994,12,,,2021-03-15T13:05:51Z,94-29987,0,0,09000064805af2eb
FDA-1993-N-0043-0002,FDA,FDA-1993-N-0043,Adverse Experience Reporting Requirements for Human Drug and Licensed Biological Products; Correction,Notice,Correction,1994-12-05T05:00:00Z,1994,12,,,2024-04-29T14:48:41Z,,0,0,09000064804fc3bb
FDA-1994-N-0035-0001,FDA,FDA-1994-N-0035,Methods of the Allergenic Products Testing Laboratory; Availability,Notice,Notice of Availability,1994-11-30T05:00:00Z,1994,11,,,2024-10-04T20:23:52Z,,0,0,09000064804fd68b
FDA-1992-N-0007-0003,FDA,FDA-1992-N-0007,FDA,Notice,N-Notice,1994-11-17T05:00:00Z,1994,11,1994-11-17T05:00:00Z,1995-02-17T04:59:59Z,2008-05-16T23:31:45Z,,0,0,0900006480525b33
FDA-1994-N-0037-0002,FDA,FDA-1994-N-0037,FDA,Notice,NEC-Notice of Extension,1994-11-16T05:00:00Z,1994,11,1994-11-16T05:00:00Z,1995-02-14T04:59:59Z,2008-05-16T23:15:39Z,,0,0,09000064804fd7ff
FDA-1993-N-0043-0001,FDA,FDA-1993-N-0043,Adverse Experience Reporting Requirements for Human Drug and Licensed Biological Products,Notice,NPR-Notice of Proposed Rule-Making,1994-11-15T05:00:00Z,1994,11,1994-11-15T05:00:00Z,1995-01-26T04:59:59Z,2024-04-29T14:42:48Z,,0,0,09000064804fc3b4
FDA-1994-M-0011-0001,FDA,FDA-1994-M-0011,"Exogen Inc., Premarket Approval of Sonic Accelerated Fracture Healing System (SAFHS)",Notice,Notice of Approval,1994-11-14T05:00:00Z,1994,11,1994-11-14T05:00:00Z,1994-12-10T04:59:59Z,2024-06-07T14:52:20Z,94-27222,0,0,09000064804fc6e1
FDA-1994-N-0030-0001,FDA,FDA-1994-N-0030,FDA,Notice,Notice of Opportunity of Hearing,1994-11-14T05:00:00Z,1994,11,1994-11-14T05:00:00Z,1994-12-10T04:59:59Z,2024-12-07T20:22:46Z,,0,0,09000064804fd3d1
FDA-1994-E-0047-0001,FDA,FDA-1994-E-0047,Determination of Regulatory Review Period for Purposes of Patent Extension; Risperdal®,Notice,General Notice,1994-10-27T04:00:00Z,1994,10,1994-10-27T04:00:00Z,1994-11-01T04:59:59Z,2024-05-23T16:08:19Z,,0,0,09000064804ff746
FDA-1993-D-0019-0001,FDA,FDA-1993-D-0019,FDA,Notice,NAD-Notice of Availability of Data,1994-09-27T04:00:00Z,1994,9,,,2008-05-16T23:22:51Z,,0,0,09000064804fa914
FDA-1976-N-0027-0004,FDA,FDA-1976-N-0027,Notice of Final Rule re Partial Stay of Regulation; Enforcement Policy,Notice,Notice of Final Rule,1994-08-25T04:00:00Z,1994,8,,,2015-10-29T20:26:59Z,,0,0,090000648051b679
FDA-1994-M-0032-0001,FDA,FDA-1994-M-0032,"Cardiac Pacemakers, Inc., Premarket Approval of VENTAK@ PRx@ Model 1700 and Model 1705 AICD Tm System, Model 2850 PRESCRIPTOR TM Programmer and Model 2860 Program Disk",Notice,Notice of Approval,1994-08-16T04:00:00Z,1994,8,1994-08-16T04:00:00Z,1994-09-15T03:59:59Z,2024-06-03T15:59:13Z,,0,0,09000064804fd418
FDA-1994-G-0039-0001,FDA,FDA-1994-G-0039,Notice of Filing re Safe Use In Food Triglyceride Containing Caprylic & Capric,Notice,Notice of Filing,1994-08-11T04:00:00Z,1994,8,1994-08-11T04:00:00Z,1994-10-05T03:59:59Z,2016-04-08T19:06:48Z,,0,0,09000064804fd8c3
FDA-1992-N-0056-0004,FDA,FDA-1992-N-0056,"Notice of Extension re Prescription Drug Marketing Act of 1987, Drug Amendments of 1992; Policies, Requirements, and Administrative Procedures; Reopening of Comment Period",Notice,Notice of Extension,1994-07-25T04:00:00Z,1994,7,1994-07-25T04:00:00Z,1994-08-16T03:59:59Z,2017-08-04T13:26:56Z,,0,0,090000648052bf07
FDA-1994-M-0008-0001,FDA,FDA-1994-M-0008,Allergan Medical Optics; Premarket Approval of the Model PC-28LB Ultraviolet-Absorbing Posterior Chamber Intraocular Lens,Notice,Notice of Approval,1994-07-21T04:00:00Z,1994,7,1994-07-21T04:00:00Z,1994-08-18T03:59:59Z,2024-05-28T11:53:44Z,94-17374,0,0,09000064804fc60a
FDA-1986-D-0038-0009,FDA,FDA-1986-D-0038,FDA,Notice,NAD-Notice of Availability of Data,1994-07-08T04:00:00Z,1994,7,,,2008-05-30T22:52:43Z,,0,0,090000648050e78f
FDA-1986-D-0038-0008,FDA,FDA-1986-D-0038,FDA,Notice,NAD-Notice of Availability of Data,1994-07-08T04:00:00Z,1994,7,,,2008-05-30T22:52:51Z,,0,0,090000648050e78e
FDA-1986-D-0038-0010,FDA,FDA-1986-D-0038,FDA,Notice,NAD-Notice of Availability of Data,1994-07-08T04:00:00Z,1994,7,,,2008-05-30T22:52:58Z,,0,0,090000648050e790
FDA-1994-M-0056-0001,FDA,FDA-1994-M-0056,"Sigmedics, Inc.; Premarket Approval of Parastep I System",Notice,Notice of Approval,1994-06-17T04:00:00Z,1994,6,1994-06-17T04:00:00Z,1994-07-15T03:59:59Z,2024-05-28T12:29:52Z,94-14315,0,0,090000648050388e
FDA-1994-F-0057-0001,FDA,FDA-1994-F-0057,Great Lakes Chemical Corp.; Filing of Food Additive Petition,Notice,Notice of Filing,1994-06-17T04:00:00Z,1994,6,1994-06-17T04:00:00Z,1994-07-15T03:59:59Z,2024-05-24T15:57:09Z,94-14371,0,0,09000064805038b0
FDA-1993-E-0006-0001,FDA,FDA-1993-E-0006,FDA,Notice,N-Notice,1994-06-17T04:00:00Z,1994,6,1994-06-17T04:00:00Z,1994-08-16T03:59:59Z,2008-05-16T23:23:12Z,,0,0,09000064804f9b7e
FDA-1994-N-0037-0001,FDA,FDA-1994-N-0037,FDA,Notice,NI-Notice of Intent,1994-06-15T04:00:00Z,1994,6,1994-06-15T04:00:00Z,1994-08-18T03:59:59Z,2008-05-16T23:15:38Z,,0,0,09000064804fd7ca
FDA-1978-N-0018-0122,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-The-Counter Human Use; Proposed Amendment to the Tentative Final Monograph; Reopening of Comment Period,Notice,Notice of Extension,1994-06-14T04:00:00Z,1994,6,1994-06-14T04:00:00Z,1994-08-23T03:59:59Z,2019-07-19T19:49:02Z,94-13933,0,0,090000648055a108
FDA-1992-N-0017-0005,FDA,FDA-1992-N-0017,FDA,Notice,NFR-Notice of Final Rule,1994-06-01T04:00:00Z,1994,6,,,2008-05-16T23:32:01Z,,0,0,0900006480526aaf
FDA-1992-N-0017-0002,FDA,FDA-1992-N-0017,FDA,Notice,NFR-Notice of Final Rule,1994-06-01T04:00:00Z,1994,6,,,2008-05-16T23:32:01Z,,0,0,0900006480526aa6
FDA-1992-N-0017-0006,FDA,FDA-1992-N-0017,FDA,Notice,NFR-Notice of Final Rule,1994-06-01T04:00:00Z,1994,6,,,2008-05-16T23:32:00Z,,0,0,0900006480526ab4
FDA-1994-M-0009-0001,FDA,FDA-1994-M-0009,OrthoLogic Corp.; Premarket Approval of Orthologic 1000,Notice,Notice of Approval,1994-06-01T04:00:00Z,1994,6,,,2024-05-28T13:34:36Z,94-12374,0,0,09000064804fc625
FDA-1992-N-0017-0004,FDA,FDA-1992-N-0017,FDA,Notice,NFR-Notice of Final Rule,1994-06-01T04:00:00Z,1994,6,,,2008-05-16T23:32:01Z,,0,0,0900006480526aac
FDA-1992-N-0017-0003,FDA,FDA-1992-N-0017,FDA,Notice,NFR-Notice of Final Rule,1994-06-01T04:00:00Z,1994,6,,,2008-05-16T23:32:01Z,,0,0,0900006480526aa9
FDA-1992-E-0012-0002,FDA,FDA-1992-E-0012,Determination of Regulatory Review Period for Purposes of Patent Extension; Supprelin; Correction,Notice,Correction,1994-05-26T04:00:00Z,1994,5,,,2023-09-25T11:46:30Z,94-9047,0,0,0900006480526109
FDA-1993-N-0057-0026,FDA,FDA-1993-N-0057,FDA,Notice,NEC-Notice of Extension,1994-05-19T04:00:00Z,1994,5,1994-05-19T04:00:00Z,1994-08-04T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc6c1
FDA-1993-N-0013-0007,FDA,FDA-1993-N-0013,FDA,Notice,NEC-Notice of Extension,1994-05-19T04:00:00Z,1994,5,1994-05-19T04:00:00Z,1994-06-04T03:59:59Z,2008-05-16T23:23:57Z,,0,0,09000064804fa495
FDA-1994-M-0019-0001,FDA,FDA-1994-M-0019,"Medtronic, Inc.; Premarket Approval of the Medtronic® Transvene® Lead System",Notice,NAL-Notice of Approval,1994-04-28T04:00:00Z,1994,4,1994-04-28T04:00:00Z,1994-05-20T03:59:59Z,2009-01-29T18:57:08Z,,0,0,09000064804fcb03
FDA-1994-M-0046-0001,FDA,FDA-1994-M-0046,"DePuy, Inc.; Premarket Approval of the Rotating Platform Configuration of the New Jersey LCSB Total Knee System",Notice,Notice of Approval,1994-04-26T04:00:00Z,1994,4,1994-04-26T04:00:00Z,1994-05-19T03:59:59Z,2024-06-04T13:21:46Z,,0,0,09000064804ff6ee
FDA-1994-N-0053-0001,FDA,FDA-1994-N-0053,Lilly Research Laboratories,Notice,Notice of Filing,1994-03-28T05:00:00Z,1994,3,,,2025-01-08T16:01:56Z,94-6290,0,0,09000064805037d3
FDA-1994-N-0031-0001,FDA,FDA-1994-N-0031,"Drug Export; Senzone (Nefazodone HCI) Tablets 50mg, 100mg, 150 mg, 200 mg, and 300 mg",Notice,Notice of Filing,1994-03-28T05:00:00Z,1994,3,1994-03-18T05:00:00Z,1994-03-29T04:59:59Z,2017-07-06T15:51:19Z,94-6292,0,0,09000064804fd3fc
FDA-1994-F-0038-0001,FDA,FDA-1994-F-0038,Analytical Systems Engineering Corp.,Notice,NFL-Notice of Filing,1994-03-02T05:00:00Z,1994,3,1994-03-02T05:00:00Z,1994-03-29T04:59:59Z,2024-05-29T01:01:04Z,,0,0,09000064804fd872
FDA-1993-N-0057-0024,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc680
FDA-1993-N-0057-0002,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc665
FDA-1993-N-0057-0001,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc660
FDA-1993-N-0057-0017,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc679
FDA-1993-N-0057-0023,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc67f
FDA-1993-N-0057-0010,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc671
FDA-1993-N-0057-0011,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc672
FDA-1993-N-0057-0004,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc668
FDA-1993-N-0057-0009,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc670
FDA-1993-N-0057-0003,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc666
FDA-1993-N-0057-0021,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc67d
FDA-1993-N-0057-0007,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc66b
FDA-1993-N-0057-0015,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc676
FDA-1993-N-0057-0006,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc66a
FDA-1993-N-0057-0022,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc67e
FDA-1993-N-0057-0025,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc681
FDA-1993-N-0057-0005,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc669
FDA-1993-N-0057-0008,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc66f
FDA-1993-N-0057-0012,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc673
FDA-1993-N-0057-0013,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc674
FDA-1993-N-0057-0016,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:17Z,,0,0,09000064804fc678
FDA-1993-N-0057-0014,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc675
FDA-1993-N-0057-0018,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:18Z,,0,0,09000064804fc67a
FDA-1993-N-0057-0019,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc67b
FDA-1993-N-0057-0020,FDA,FDA-1993-N-0057,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1994-02-22T05:00:00Z,1994,2,1994-02-22T05:00:00Z,1994-05-06T03:59:59Z,2008-05-16T23:24:16Z,,0,0,09000064804fc67c
FDA-1993-F-0046-0001,FDA,FDA-1993-F-0046,Rio Linda Chemical Co Inc; Filing of Food Additive Petition,Notice,Notice of Filing,1994-02-09T05:00:00Z,1994,2,1994-02-09T05:00:00Z,1994-03-25T04:59:59Z,2024-05-23T01:00:47Z,94-2268,0,0,09000064804fc49a
FDA-1987-N-0027-0158,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:14Z,,0,0,090000648046c3ec
FDA-1987-N-0027-0159,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:14Z,,0,0,090000648046c3ed
FDA-1987-N-0027-0157,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:20Z,,0,0,090000648046c3eb
FDA-1987-N-0027-0160,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:07Z,,0,0,090000648046c3ee
FDA-1987-N-0027-0161,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:14Z,,0,0,090000648046c3ef
FDA-1987-N-0027-0156,FDA,FDA-1987-N-0027,FDA,Notice,NAD-Notice of Availability of Data,1994-02-07T05:00:00Z,1994,2,,,2008-05-30T22:53:00Z,,0,0,090000648046c3ea
FDA-1978-N-0027-0003,FDA,FDA-1978-N-0027,Talc; Consumer Uses and Health Perspectives; Public Meetings,Notice,General Notice,1994-01-31T05:00:00Z,1994,1,1994-01-14T05:00:00Z,1994-03-03T04:59:59Z,2019-08-01T14:55:18Z,94-1083,0,0,0900006480560ccb
FDA-1993-N-0013-0001,FDA,FDA-1993-N-0013,FDA,Notice,NM-Notice of Meeting,1994-01-31T05:00:00Z,1994,1,,,2008-05-16T23:23:57Z,,0,0,09000064804fa433
FDA-1993-N-0050-0001,FDA,FDA-1993-N-0050,FDA,Notice,N-Notice,1994-01-07T05:00:00Z,1994,1,1994-01-07T05:00:00Z,1994-07-02T03:59:59Z,2008-05-16T23:24:13Z,,0,0,09000064804fc559
FDA-1993-N-0031-0001,FDA,FDA-1993-N-0031,Dietary Supplements; Establishment of Date of Application,Notice,Notice of Final Rule,1994-01-06T05:00:00Z,1994,1,,,2024-05-15T16:33:28Z,93-31812,0,0,09000064804fb71b
FDA-1993-G-0001-0001,FDA,FDA-1993-G-0001,"Purac America, Inc.",Notice,NFL-Notice of Filing,1994-01-03T05:00:00Z,1994,1,1994-01-03T05:00:00Z,1994-02-26T04:59:59Z,2008-05-16T23:23:41Z,,0,0,09000064804f9933
FDA-1992-N-0005-0002,FDA,FDA-1992-N-0005,Susan M. Long; Denial of Hearing and Final Debarment Order- ENVELOPE,Notice,Notice of Denial,1994-01-03T05:00:00Z,1994,1,,,2023-08-03T14:04:46Z,,0,0,09000064805256e2
FDA-1992-N-0005-0001,FDA,FDA-1992-N-0005,Susan M. Long; Denial of Hearing and Final Debarment Order,Notice,Notice of Denial,1994-01-03T05:00:00Z,1994,1,,,2024-11-12T04:13:41Z,93-31337,1,0,0900006480525664